“…Recent studies involving entry pathways (e.g., clathrin-vs. caveolar-mediated endocytosis) and entry kinetics (e.g., few vs. many hours) of HPV have suffered due to a lack of consistency (Bousarghin et al, 2003;Culp and Christensen, 2004;Hindmarsh and Laimins, 2007;Smith et al, 2007;Laniosz et al, 2008). This may be due to the use of multiple types of synthetic papillomavirus particles and cell lines, in addition to the use of native virions, and cross-talk between clathrin and caveolar pathways (Fligge et al, 2001;Bousarghin et al, 2003;Hindmarsh and Laimins, 2007;Schelhaas et al, 2007;Laniosz et al, 2008). Recent discoveries with polyomaviruses suggest that controversies over papillomavirus entry may be from the initial usage of clathrin-mediated endocytosis and later exploitation of caveolar endocytic machinery within the cell (Bousarghin et al, 2003;Querbes et al, 2006;Laniosz et al, 2008).…”